Maurizio Moroni

DeA Capital Alternative Funds SGR SpA (Dea Capital Alternative Funds) is a private equity subsidiary of DeA Capital SpA (Private Equity) founded in 2000. The firm is headquartered in Milan, Italy.

Micromed SpA engages in the manufacture of electro medical devices designed for neurophysiology diagnosis. Its products specialize in the use for neurophysiology laboratories, neurology departments, children’s neuropsychiatry department, epilepsy centers and sleep research centers. The company was founded by Claudio Perissinotto and Cipriano Castelllaro in 1982 and is headquartered in Mogliano Veneto, Italy.

Diesse Diagnostica Senese SpA develops in vitro diagnostics systems. It specializes in diagnostic kits which include blood analyzers and collection tubes and reagents used in the fields of hematology, seroimmunology, and bacteriology. The company was founded in 1980 and is headquartered in Monteriggioni, Italy.

COREALIS Pharma, Inc. manufactures pharmaceutical drugs. The company is based in Laval, Canada. The Canadian company was founded in 2005 by Patrick Gosselin, Yves Mouget, Yves Roy.

Imprima SpA engages in the development of textile printing and finishing processes. The company was founded on February 1, 2017 and is headquartered in Milan, Italy.

KBC Fashion Holding GmbH provides investment services. The private company is based in Lorrach, Germany. The CEOs of the German company are Gianluca Boni, Valentina Franceschini.

Ad-Tech Medical Instrument Corp. was founded in 1983 and is based in Oak Creek, WI. The company specializes in providing state-of-the-art electrodes for physicians to record, monitor, and stimulate subsurface levels of the brain. Ad-Tech also offers a range of additional products, including brain biopsy needles, sphenoidal electrodes, and transectors. The company's electrode devices are used for EEG monitoring and brain mapping for epilepsy and brain diseases. Neurosurgeons worldwide rely on Ad-Tech for the electrodes used to treat intractable epilepsy.

ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France.